Literature DB >> 29289669

Ambulation and survival following surgery in elderly patients with metastatic epidural spinal cord compression.

Eyal Itshayek1, Carlos Candanedo2, Shifra Fraifeld2, Amir Hasharoni3, Leon Kaplan3, Josh E Schroeder3, José E Cohen2.   

Abstract

BACKGROUND AND CONTEXT: Metastatic epidural spinal cord compression (MESCC) is a disabling consequence of disease progression. Surgery can restore or preserve physical function, improving access to treatments that increase duration of survival; however, advanced patient age may deter oncologists and surgeons from considering surgical management.
PURPOSE: Evaluate the duration of ambulation and survival in elderly patients following surgical decompression of MESCC. STUDY DESIGN/
SETTING: Retrospective file review of a prospective database, under institutional review board (IRB) waiver of informed consent, of consecutive patients treated in an academic tertiary care medical center from August 2008 to March 2015. PATIENT SAMPLE: Patients ≥65 years presenting neurological and/or radiological signs of cord compression because of metastatic disease, who underwent surgical decompression. OUTCOME MEASURES: Duration of ambulation and survival.
METHODS: Patients underwent urgent multidisciplinary evaluation and surgery. Ambulation and survival were compared with age, pre-, and postoperative neurological (American Spinal Injury Association [ASIA] Impairment Scale [AIS]) and performance status (Karnofsky Performance Status [KPS]), and Tokuhashi Score using Kruskal-Wallis and Wilcoxon signed rank tests, Pearson correlation coefficient, Cox regression model, log-rank analysis, and Kaplan-Meier analysis.
RESULTS: Forty patients were included (21 male, 54%; mean age 74 years, range 65-87). Surgery was performed a mean 3.8 days after onset of motor symptoms. Mean duration of ambulation and survival were 474 (range 0-1662) and 525 days (range 11-1662), respectively; 53% of patients (21 of 40) survived and 43% (17 of 40) retained ambulation for ≥1 year. There was no significant relationship between survival and ambulation for patients aged 65-69, 70-79, or 80-89 years, although Kaplan-Meier analysis suggested stratification. There was a significant relationship between duration of ambulation and pre- and postoperative AIS (p=.0342, p=.0358, respectively) and postoperative KPS (p=.0221). Tokuhashi score was not significantly related to duration of survival or ambulation, and greatly underestimated life expectancy in 22 of 37 (59%) patients with scores 0-11.
CONCLUSIONS: Decompressive surgery led to marked improvement in neurological function and performance status. More than 50% of patients survived for >1 year, some for 3 years or more after surgery.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aged; Spinal cord compression (metastatic epidural); Spinal metastases; Surgical oncology; Survival; Walking

Mesh:

Year:  2017        PMID: 29289669     DOI: 10.1016/j.spinee.2017.11.020

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  6 in total

1.  The next generation in surgical research for patients with spinal metastases.

Authors:  Andrew J Schoenfeld; Marco L Ferrone
Journal:  Spine J       Date:  2018-07-26       Impact factor: 4.166

2.  Outcomes of surgical treatments of spinal metastases: a prospective study.

Authors:  C Bouthors; S Prost; C Court; B Blondel; Y P Charles; S Fuentes; H P Mousselard; C Mazel; C H Flouzat-Lachaniette; P Bonnevialle; F Saihlan
Journal:  Support Care Cancer       Date:  2019-08-09       Impact factor: 3.603

Review 3.  A systematic review of MIS and open decompression surgery for spinal metastases in the last two decades.

Authors:  Bhoresh Dhamija; Dheeraj Batheja; Birender Singh Balain
Journal:  J Clin Orthop Trauma       Date:  2021-09-25

4.  A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2 Years Following Treatment: Survival and Functional Outcomes.

Authors:  Grace X Xiong; Miles W A Fisher; Joseph H Schwab; Andrew K Simpson; Lananh Nguyen; Daniel G Tobert; Tracy A Balboni; John H Shin; Marco L Ferrone; Andrew J Schoenfeld
Journal:  Spine (Phila Pa 1976)       Date:  2022-04-01       Impact factor: 3.468

Review 5.  Evaluating ambulatory function as an outcome following treatment for spinal metastases: a systematic review.

Authors:  Lananh Nguyen; Nicole Agaronnik; Marco L Ferrone; Jeffrey N Katz; Andrew J Schoenfeld
Journal:  Spine J       Date:  2021-05-13       Impact factor: 4.297

6.  Treatment Outcomes in Spinal Metastatic Disease With Indeterminate Stability.

Authors:  Brian L Dial; Anthony A Catanzano; Valentine Esposito; John Steele; Amanda Fletcher; Sean P Ryan; John P Kirkpatrick; C Rory Goodwin; Jordon Torok; Thomas Hopkins; Sergio Mendoza-Lattes
Journal:  Global Spine J       Date:  2020-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.